Clinical Trial Update: A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing pre-operative IMRT plus surgery versus surgery alone for primary retroperitoneal sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retroperitoneal Sarcoma
• Soft Tissue Sarcoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 3 | Status: COMPLETED